From the Brandon Sun:
Dozens of multiple sclerosis patients asked federal health advisers Tuesday to let them decide whether to take Tysabri, a promising drug that was pulled from the market after it was linked to a rare, often-fatal brain infection.
‘‘I am at the end of my road, in terms of what I can take. I want it to be my choice,’’ said Barbara Crooks, 48, who travelled with her husband, David, from the Pittsburgh area to testify before a U.S. Food and Drug Administration advisory committee. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment